YRK York Pharma

    RNS Number : 2068J
  York Pharma plc
  28 November 2008
   

    York Pharma plc

    Equity Placing


    London, UK, 28 November 2008 York Pharma plc (AIM: YRK), the pharmaceutical company focused on the field of dermatology, announces that
250,000 new York Pharma 5p ordinary shares (the "Shares") have been issued and allotted to Lanstead Capital L.P. at a price of 60 pence per
share in accordance with the terms of an agreement between the parties dated 31 July 2008. 

    Application has been made to the London Stock Exchange plc for the Placing Shares to be admitted to trading on AIM. It is expected that
the allotment, issue and admission of the Shares to trading on AIM will become effective and that dealings in such shares will commence on 3
December 2008.

    --END--

    For further information please contact:

 York Pharma plc                        Tel: +44 (0)870 067 2563 
 Terry Sadler, Chief Executive Officer

 FinnCap                                Tel: +44 (0)207 600 1658 
 Stephen Norcross

 Collins Stewart Europe Limited         Tel: +44 (0)207 8000 8350 
 Nick Ellis

 Financial Dynamics                     Tel: +44 (0)207 831 3113 
 David Yates
 Ben Brewerton
 Emma Thompson


    About York Pharma plc
    York Pharma is an AIM-listed strategic acquirer, developer and marketer of pharmaceutical products in the field of dermatology. Its
portfolio now embraces skin diseases that make up approximately 87% of the global US$10.6bn dermatology market.  For further information,
please go to www.yorkpharma.com.



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
IOEEASFPALDPFFE

York Pharma (LSE:YRK)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

York Pharma (LSE:YRK)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024